Short answer: Melasma and stubborn facial pigmentation are usually managed with a combination of topical actives — hydroquinone, tretinoin and a mild corticosteroid in the classic triple combination, plus alternatives such as tranexamic acid, azelaic acid, kojic acid, niacinamide, cysteamine and vitamin C. A compounding pharmacy adds value by preparing a topical to one patient’s exact prescription: the specific actives a doctor chooses, at the strengths and in the base they specify, and adjusted over time as the skin settles or the plan moves from active treatment to maintenance. At Lynnity this is prescription-only — many of these actives (hydroquinone, tretinoin, corticosteroids) are prescription medicines, and every preparation is made solely on the prescription of a registered doctor and prepared under the Ministry of Health’s Good Compounding Practice (GCP) guideline. It is not a mass-produced, MAL-registered product and cannot be bought over the counter or online.
Melasma is one of the most common pigmentary complaints seen in Malaysian and Singaporean skin clinics — driven by intense year-round UV, heat, hormonal factors and a predominantly higher-Fitzpatrick population that pigments readily and is prone to rebound. This guide is written for prescribers and referring practitioners: what the topical actives actually do, where compounding earns its place over a fixed off-the-shelf cream, and how a clinic in KL, Klang Valley or Singapore works with a compounding pharmacy — always through a doctor’s prescription.
Why melasma is hard, and why one fixed cream rarely fits
Melasma is a chronic, relapsing condition rather than a one-course problem. It responds slowly, it commonly rebounds when treatment stops or when sun exposure spikes, and higher-Fitzpatrick skin carries a real risk of post-inflammatory hyperpigmentation if an active is too strong or a preparation is too irritating. That combination — chronic, relapsing and irritation-sensitive — is exactly why a single fixed-strength commercial cream is often a blunt instrument. The strength that clears an early plaque may be too irritating for maintenance; the formula that suits one patient’s skin may sting or provoke rebound in another.
The pigment-lowering actives themselves work through different pathways. Hydroquinone reduces melanin production; tretinoin speeds cell turnover and helps other actives penetrate; a mild corticosteroid calms the irritation those two can cause and reduces the inflammatory drive to pigment. Tranexamic acid works upstream on the signalling that stimulates pigment cells and, usefully, does not bleach the skin. Azelaic acid, kojic acid, niacinamide, cysteamine and vitamin C each nudge different steps in melanin formation. Combining actives that hit different pathways is the accepted principle; how they are combined, at what strengths, and in what base is where clinical judgement — and compounding — comes in.
The common topical actives, at a glance
The table below is orientation for prescribers, not a recommendation for any individual patient. Active selection, strength and combination are clinical decisions; the pharmacy prepares what is prescribed.
| Active | General role (evidence-hedged) | Prescribing / safety note |
|---|---|---|
| Hydroquinone | Long-standing first-line depigmenting agent; the anchor of the classic triple combination. Studies support meaningful lightening of melasma over weeks to months. | Prescription medicine. Intended for defined courses, not indefinite use; prolonged high-strength use carries a risk of ochronosis and irritation, which is one reason prescribers step strength down over time. |
| Tretinoin | Retinoid that increases turnover and improves penetration of other actives. | Prescription medicine. Irritating in higher strengths; contraindicated in pregnancy. Strength is often titrated to tolerance. |
| Corticosteroid (mild) | Calms irritation from hydroquinone and tretinoin and dampens the inflammatory pigment drive; the third element of the triple combination. | Prescription medicine. Used short-term within a combination, not as a standalone long-term agent, to avoid steroid-related skin effects. |
| Tranexamic acid (topical) | Acts on the signalling that activates pigment cells; studies suggest benefit in melasma and it does not bleach the skin, giving a gentler long-term profile. | Increasingly used as part of maintenance or for patients who cannot tolerate hydroquinone. Oral tranexamic acid is a separate, prescriber-led decision. |
| Azelaic acid | Lowers pigment production and is anti-inflammatory; a useful non-hydroquinone option. | Generally well tolerated; considered acceptable in pregnancy by many prescribers, but that is a clinical decision. |
| Kojic acid / niacinamide / cysteamine / vitamin C | Adjuncts that each target different steps in melanin formation; often added to reduce reliance on hydroquinone or to support maintenance. | Generally gentler; evidence varies by active and is often modest. Chosen to build a tolerable, sustainable regimen. |
An honest caveat to share with clinics: melasma has no cure, and no topical clears it permanently. The realistic goal is meaningful, gradual lightening and control, held with maintenance and rigorous daily photoprotection. Much online content overstates how completely pigmentation can be erased; the defensible position is that combinations of evidence-backed actives, matched to the individual and paired with sun protection, can improve appearance and reduce relapse — not eliminate the tendency to pigment.
Where compounding adds value
The exact actives and strengths — and the ability to change them
A fixed commercial cream commits the patient to one set of actives at one strength. A compounded topical is built to the prescription, so a prescriber can specify the precise combination and each active’s strength — a higher-strength phase to settle active pigmentation, then a stepped-down or hydroquinone-free maintenance formula once the skin improves. Adjusting a fixed product means switching brands; adjusting a compounded one is simply the next prescription.
Removing the steroid for maintenance
The triple combination is designed for defined active-treatment courses because of the corticosteroid. Compounding lets a prescriber prepare a steroid-free maintenance version — for example tranexamic acid with azelaic acid and niacinamide — so a patient can stay on a gentler regimen between active phases without the risks of long-term steroid use.
A base and vehicle suited to the skin
Because the pharmacy builds from raw actives, the prescription can specify a cream, gel or lotion base chosen for the patient’s skin type and for the KL climate — a lighter vehicle for oilier or humid-weather skin, a richer one for a drier or more sensitive face — and can leave out a fragrance or excipient a reactive patient does not tolerate. This overlaps with the excipient-free and allergen-aware compounding many skin clinics already use.
Titrating for irritation-prone, higher-Fitzpatrick skin
In skin prone to post-inflammatory hyperpigmentation, getting the strength right matters more than reaching for the strongest formula. Compounding lets a prescriber start conservatively and step up only if needed, reducing the risk that an over-strong preparation provokes the very pigmentation it is meant to treat.
The evidence, stated honestly
It is worth being straight with clinics, because pigmentation content online often runs well ahead of the data.
On the firmer side: the hydroquinone-based triple combination has the strongest and longest evidence base for melasma; tranexamic acid, topical and oral, has a growing body of supportive studies and the advantage of not bleaching skin; and azelaic acid and vitamin C have reasonable evidence as adjuncts. Combining actives that work through different pathways is a well-accepted principle.
At the same time, several expectations need managing. Melasma is chronic and relapsing — improvement is gradual and maintenance is usually lifelong in practice. No topical works without disciplined daily photoprotection; UV undoes progress faster than any active builds it, which matters especially in Malaysia’s year-round sun. And stronger is not better: over-aggressive treatment in higher-Fitzpatrick skin can cause rebound or post-inflammatory pigmentation. The honest position for a clinic is that a personalised, well-tolerated regimen sustained over time beats a strong, short-lived one — and that outcomes vary between patients.
Where a clinic fits: the referral and prescribing workflow
A personalised, compounded pigmentation topical follows the same disciplined route as any compounded preparation at Lynnity, and it always starts with a prescriber — never with the pharmacy.
Prescribe directly
A registered doctor assesses the patient’s skin, confirms the diagnosis, decides which actives and strengths are appropriate, and writes a prescription specifying each active, its strength, the base, the quantity and the directions. The clinic sends it to the pharmacy; Lynnity confirms feasibility and compatibility, prepares the topical under GCP, and dispenses it back to the patient. Moving from an active-phase formula to a maintenance one goes back through the same loop as a fresh prescription.
Refer to a prescriber first
A non-prescribing practitioner — an aesthetician or a wellness-clinic therapist, say — who sees a patient with pigmentation refers them to a registered doctor for assessment. The doctor reviews, decides and writes the prescription; only then does the pharmacy prepare it. A compounding pharmacy cannot supply a prescription-active topical on a non-prescriber’s request alone, and no reputable one will imply otherwise. There is no “no prescription needed” route.
Both patterns share the same anchor: a registered doctor’s prescription sits at the centre, and the pharmacy prepares strictly to it under Good Compounding Practice (GCP) — the Ministry of Health guideline covering how compounded preparations are made, checked, labelled and documented. GCP is the correct standard for pharmacy compounding, and it is distinct from GMP, which governs mass manufacturing. Lynnity is a compounding pharmacy, not a manufacturer or a skincare brand: it does not mass-produce or contract-manufacture products, and it prepares only what a prescriber specifies for a named patient.
A note for Singapore clinics
Clinics in Singapore sometimes ask whether a Malaysian compounding pharmacy can prepare a personalised pigmentation topical against a Singapore prescription. Cross-border supply of compounded, prescription-only preparations is governed by the receiving country’s own rules, which differ from Malaysia’s. Confirm the position with your own regulator before assuming a preparation can cross the border, and treat this article as general orientation rather than a compliance opinion.
Frequently asked questions
What is the classic triple combination for melasma?
It is a topical combining hydroquinone (to lower melanin production), tretinoin (to speed turnover and aid penetration) and a mild corticosteroid (to calm irritation and inflammation). It has the strongest evidence base for melasma but is intended for defined courses rather than indefinite use. All three are prescription medicines, so the preparation is prescription-only.
Why compound a pigmentation cream instead of using an off-the-shelf product?
Compounding lets a prescriber specify the exact actives and strengths, prepare a steroid-free maintenance version, choose a base suited to the patient’s skin and the local climate, leave out a fragrance or excipient a patient reacts to, and adjust the formula as the skin settles — levers a fixed retail product cannot offer.
Is tranexamic acid better than hydroquinone for melasma?
They work differently and are often used together or in sequence rather than ranked. Hydroquinone has the longest evidence base; tranexamic acid acts on the signalling that stimulates pigment cells, does not bleach the skin, and is increasingly used for maintenance or for patients who cannot tolerate hydroquinone. Which to use, and in what combination, is a prescriber’s decision.
Can melasma be cured?
No. Melasma is a chronic, relapsing condition. Personalised topicals paired with strict daily sun protection can lighten pigmentation and reduce relapse, but they do not remove the underlying tendency to pigment, and results vary between patients. Maintenance is usually ongoing.
Do compounded pigmentation topicals still need a prescription?
Yes. Many of the actives — hydroquinone, tretinoin, corticosteroids — are prescription medicines, and every Lynnity preparation is made solely on the prescription of a registered doctor. There is no direct-purchase or “no prescription needed” route. A referring practitioner sends the patient to a doctor, who assesses and prescribes.
Are compounded pigmentation topicals MAL-registered?
No. A compounded preparation is made to order for one patient and does not carry an MAL registration, which applies to mass-manufactured products. It is prepared under Good Compounding Practice (GCP) on a doctor’s prescription.
We’re a skin clinic in KL — how do we start prescribing personalised pigmentation topicals through Lynnity?
Contact us through lynnitypharma.com and ask to speak with a pharmacist. We can talk through the actives available, workable strengths and bases, steroid-free maintenance options, and beyond-use dating before your first prescription is sent.
Reviewed by the Lynnity pharmacy team — registered pharmacists compounding to Good Compounding Practice (GCP) in Kuala Lumpur.
This article is general information for healthcare practitioners and is not medical advice. It does not diagnose, treat or recommend therapy for any condition. All Lynnity preparations require a prescription from a registered doctor.